BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34638956)

  • 21. NR2F1 contributes to cancer cell dormancy, invasion and metastasis of salivary adenoid cystic carcinoma by activating CXCL12/CXCR4 pathway.
    Gao XL; Zheng M; Wang HF; Dai LL; Yu XH; Yang X; Pang X; Li L; Zhang M; Wang SS; Wu JB; Tang YJ; Liang XH; Tang YL
    BMC Cancer; 2019 Jul; 19(1):743. PubMed ID: 31357956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the HIF‑1α/SDF‑1/CXCR4 signaling axis in accelerated fracture healing after craniocerebral injury.
    Xue Y; Li Z; Wang Y; Zhu X; Hu R; Xu W
    Mol Med Rep; 2020 Oct; 22(4):2767-2774. PubMed ID: 32945380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CXCR4/SDF1 axis improves muscle regeneration through MMP-10 activity.
    Bobadilla M; Sainz N; Abizanda G; Orbe J; Rodriguez JA; Páramo JA; Prósper F; Pérez-Ruiz A
    Stem Cells Dev; 2014 Jun; 23(12):1417-27. PubMed ID: 24548137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The chemokine SDF1/CXCL12 and its receptor CXCR4 regulate mouse germ cell migration and survival.
    Molyneaux KA; Zinszner H; Kunwar PS; Schaible K; Stebler J; Sunshine MJ; O'Brien W; Raz E; Littman D; Wylie C; Lehmann R
    Development; 2003 Sep; 130(18):4279-86. PubMed ID: 12900445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypermethylation of microRNA-149 activates SDF-1/CXCR4 to promote osteogenic differentiation of mesenchymal stem cells.
    Li G; An J; Han X; Zhang X; Wang W; Wang S
    J Cell Physiol; 2019 Dec; 234(12):23485-23494. PubMed ID: 31206187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model.
    Mercurio L; Ajmone-Cat MA; Cecchetti S; Ricci A; Bozzuto G; Molinari A; Manni I; Pollo B; Scala S; Carpinelli G; Minghetti L
    J Exp Clin Cancer Res; 2016 Mar; 35():55. PubMed ID: 27015814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and functional heterogeneity of chemokine receptors CXCR4 and CXCR7 in primary patient-derived glioblastoma cells.
    Liu C; Pham K; Luo D; Reynolds BA; Hothi P; Foltz G; Harrison JK
    PLoS One; 2013; 8(3):e59750. PubMed ID: 23555768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.
    Wu M; Chen Q; Li D; Li X; Li X; Huang C; Tang Y; Zhou Y; Wang D; Tang K; Cao L; Shen S; Li G
    J Cell Biochem; 2008 Jan; 103(1):245-55. PubMed ID: 17549698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mast cell accumulation in glioblastoma with a potential role for stem cell factor and chemokine CXCL12.
    Põlajeva J; Sjösten AM; Lager N; Kastemar M; Waern I; Alafuzoff I; Smits A; Westermark B; Pejler G; Uhrbom L; Tchougounova E
    PLoS One; 2011; 6(9):e25222. PubMed ID: 21949886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CXCL12/CXCR4 promotes proliferation, migration, and invasion of adamantinomatous craniopharyngiomas via PI3K/AKT signal pathway.
    Yin X; Liu Z; Zhu P; Wang Y; Ren Q; Chen H; Xu J
    J Cell Biochem; 2019 Jun; 120(6):9724-9736. PubMed ID: 30582214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of the SDF‑1/CXCR4/β‑catenin axis contributes to bladder cancer cell growth inhibition in vitro and in vivo.
    Zhang T; Yang F; Li W; Liu B; Li W; Chen Z; Wang C
    Oncol Rep; 2018 Sep; 40(3):1666-1674. PubMed ID: 30015971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis.
    Uygur B; Wu WS
    Mol Cancer; 2011 Nov; 10():139. PubMed ID: 22074556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells.
    Chen G; Chen SM; Wang X; Ding XF; Ding J; Meng LH
    J Biol Chem; 2012 Apr; 287(15):12132-41. PubMed ID: 22337890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CXCL12-induced glioblastoma cell migration requires intermediate conductance Ca2+-activated K+ channel activity.
    Sciaccaluga M; Fioretti B; Catacuzzeno L; Pagani F; Bertollini C; Rosito M; Catalano M; D'Alessandro G; Santoro A; Cantore G; Ragozzino D; Castigli E; Franciolini F; Limatola C
    Am J Physiol Cell Physiol; 2010 Jul; 299(1):C175-84. PubMed ID: 20392929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway.
    Tabouret E; Tchoghandjian A; Denicolai E; Delfino C; Metellus P; Graillon T; Boucard C; Nanni I; Padovani L; Ouafik L; Figarella-Branger D; Chinot O
    Oncotarget; 2015 May; 6(13):11664-75. PubMed ID: 25860928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma.
    Rempel SA; Dudas S; Ge S; Gutiérrez JA
    Clin Cancer Res; 2000 Jan; 6(1):102-11. PubMed ID: 10656438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The involvement of anterior gradient 2 in the stromal cell-derived factor 1-induced epithelial-mesenchymal transition of glioblastoma.
    Xu C; Liu Y; Xiao L; Guo C; Deng S; Zheng S; Zeng E
    Tumour Biol; 2016 May; 37(5):6091-7. PubMed ID: 26608373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth factor receptor-Src-mediated suppression of GRK6 dysregulates CXCR4 signaling and promotes medulloblastoma migration.
    Yuan L; Zhang H; Liu J; Rubin JB; Cho YJ; Shu HK; Schniederjan M; MacDonald TJ
    Mol Cancer; 2013 Mar; 12():18. PubMed ID: 23497290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COUP-TFI modifies CXCL12 and CXCR4 expression by activating EGF signaling and stimulates breast cancer cell migration.
    Boudot A; Kerdivel G; Lecomte S; Flouriot G; Desille M; Godey F; Leveque J; Tas P; Le Dréan Y; Pakdel F
    BMC Cancer; 2014 Jun; 14():407. PubMed ID: 24906407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
    Khare T; Bissonnette M; Khare S
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.